The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
CTMC and Einstein Hospital Israelita in Brazil Partner to Launch the Global Cell Therapy Network Alliance
The CTMC Network Alliance aims to democratize and accelerate cell therapies to cancer patients globally Read the full press release: CTMC - Einstein...
CTMC Appoints Amy Hay as Chief Business Officer and Duane Avant as Chief Technical Officer
HOUSTON, TX, February 5, 2025 — CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has appointed Amy Hay as Chief Business...
CTMC and Syenex Launch Partnership to Accelerate Scalability of Cell Therapies
Houston, TX and Chicago, IL - January 8, 2025: CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership...
Recent News
Advanced therapies and technology point to the future for hematological cancers, but access remains a challenge.
Experts from Brazil and around the world participated in debates held at the Einstein venue during the most important global congress in the field....
CTMC maps out plans to democratize cell therapy
by Dr. Phalguni Deswal / Drug & Device World CTMC’s Amy Hay details a partnership model to share knowledge and expand cell therapy access...
BioProcess International: CTMC discusses journey toward democratizing cell therapy
The venture hopes to expand cell therapies in and beyond Latin America after gaining its first international partner, based in Brazil. Millie...
BioCompare: The Next Generation of CAR T: Building Cancer Killers Inside the Body
by Lauren Tanabe Read the article here:...
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
Author(s)Feliza Mirasol In this episode of Drug Digest, the discussion centers around the optimization of biopharmaceutical manufacturing and supply...
BioProcess International eBook: Autologous Cell Therapies — Shoring Up Supply Chains for Scalability
This eBook collects perspectives from around the cell-therapy industry on ways to ameliorate the scale-related and logistical limitations of...
Tying Advanced Biomanufacturing to a Clinic
By Gail Dutton Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic...
Opinion: To Scale Cell Therapy, Regional Manufacturing Is the Smart Middle Path
By Jane Koo The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between...
Navigating cell therapy’s maze of risks
How a strategic, collaborative approach can accelerate product development and bring cell therapies to patients Jason Bock, Ph.D. Access the...